Medicina · 2023 · 11 citations · 34 references
MedicineNephrologyNutritional SciencesDialysisHemodialysisRenal Replacement TherapyChronic Kidney DiseaseDialysate CompositionRenal DiseaseRenal InflammationRenal NutritionGut Microbiota CompositionInflammation In HemodialysisInflammatory Responses To HemodialysisIntestinal Microbiota EffectsOxidative Stress In HemodialysisUremic ComplicationsUremic Toxin AccumulationUremic Toxins
Introduction: Numerous studies to date have shown that the development of dysbiotic gut microbiota is a characteristic finding in chronic kidney disease (CKD). A number of uremic toxins progressively accumulate in the course of CKD, some of them generated by the intestinal microbiome, such as indoxyl sulfate (IS) and p-cresyl sulfate (p-CS). They are found to be involved in the pathogenesis of certain complications of uremic syndrome, including low-grade chronic inflammation and oxidative stress. The aim of the present study is to research the serum concentration of IS and p-CS in end stage renal disease (ESRD) patients undergoing conventional hemodialysis, as well as to study the possibilities of influencing some markers of inflammation and oxidative stress after taking a synbiotic. Materials and Methods: Thirty patients with end-stage renal disease (ESRD) undergoing hemodialysis treatment who were taking a synbiotic in the form of Lactobacillus acidophilus La-14 2 × 1011 (CFU)/g and prebiotic fructooligosaccharides were included in the study. Serum levels of total IS, total p-CS, Interleukin-6 (IL-6), and Malondialdehyde (MDA) were measured at baseline and after 8 weeks. Results. The baseline values of the four investigated indicators in the patients were significantly higher—p-CS (29.26 ± 58.32 pg/mL), IS (212.89 ± 208.59 ng/mL), IL-6 (13.84 ± 2.02 pg/mL), and MDA (1430.33 ± 583.42 pg/mL), compared to the results obtained after 8 weeks of intake, as we found a significant decrease in the parameters compared to the baseline—p-CS (6.40 ± 0.79 pg/mL, p = 0.041), IS (47.08 ± 3.24 ng/mL, p < 0.001), IL-6 (9.14 ± 1.67 pg/mL, p < 0.001), and MDA (1003.47 ± 518.37 pg/mL, p < 0.001). Conclusions: The current study found that the restoration of the intestinal microbiota in patients with CKD significantly decreases the level of certain uremic toxins. It is likely that this favorably affects certain aspects of CKD, such as persistent low-grade inflammation and oxidative stress.
34
Diversity of the Human Intestinal Microbial Flora
Paul B. Eckburg, Elisabeth M. Bik, Çharles N. Bernstein et al. · Science · 2005 · 7.8K citations · Full text
Life Sciences, Biology, Microbiology +17
Chronic kidney disease alters intestinal microbial flora
Nosratola D. Vaziri, Jakk Wong, Madeleine V. Pahl et al. · Kidney International · 2012 · 1.1K citations · Full text
Fellype Carvalho Barreto, Daniela Veit Barreto, Sophie Liabeuf et al. · Clinical Journal of the American Society of Nephrology · 2009 · 905 citations · Full text
Medicine, Biochemistry, Nephrology +15
Jian Xu, Jeffrey I. Gordon · Proceedings of the National Academy of Sciences · 2003 · 848 citations · Full text
Life Sciences, Biology, Microbiology +17
Jakk Wong, Yvette M. Piceno, Todd Z. DeSantis et al. · American Journal of Nephrology · 2014 · 632 citations · Full text